Many women with breast cancer experience symptoms of pain, fatigue, and depression, collectively known as psychoneurologic (PN) symptoms, during and after chemotherapy treatment. Evidence that inflammatory dysfunction related to cancer and its treatments contributes to the development and persistence of PN symptoms through several interrelated pathways is accumulating. However, a major limiting factor in more precisely identifying the biological mechanisms underlying these symptoms is the lack of biological measures that represent a holistic spectrum of biological responses. Metabolomics allows for examination of multiple, co-occurring metabolic pathways and provides a systems-level perspective on biological mechanisms that may contribute to PN symptoms.
Methods:
In this pilot study, we performed serum metabolome analysis using liquid chromatography high-resolution mass spectrometry of global and targeted metabolomics from the tryptophan pathway from archived samples from 19 women with early-stage breast cancer. We used paired t tests to compare metabolite concentrations and Pearson’s correlation coefficients to examine concomitant changes in metabolite concentrations and PN symptoms before and after chemotherapy.
Results:
Levels of pain, fatigue, and depression increased after chemotherapy. Compared with pre-chemotherapy, global metabolites post-chemotherapy were characterized by higher concentrations of acetyl-l-alanine and indoxyl sulfate and lower levels of 5-oxo-l-proline. Targeted analysis indicated significantly higher kynurenine levels and kynurenine/tryptophan ratios post-chemotherapy. Symptoms of pain and fatigue had strong associations with multiple global and several targeted metabolites.
Conclusion:
Results demonstrated that metabolomics may be useful for elucidating biological mechanisms associated with the development and severity of PN symptoms, specifically pain and fatigue, in women with early-stage breast cancer.
AeinehbandS.BrennerP.StåhlS.BhatM.FidockM. D.KhademiM.…PiehlF. (2016). Cerebrospinal fluid kynurenines in multiple sclerosis; Relation to disease course and neurocognitive symptoms. Brain, Behavior, and Immunity, 51, 47–55. doi:10.1016/j.bbi.2015.07.016
2.
BarnardJ.RubinD. B. (1999). Miscellanea. Small-sample degrees of freedom with multiple imputation. Biometrika, 86, 948–955. doi:10.1093/biomet/86.4.948
3.
BegerR. D.DunnW.SchmidtM. A.GrossS. S.KirwanJ. A.CascanteM.…Kaddurah-DaoukR. (2016). Metabolomics enables precision medicine: “A white paper, community perspective.”Metabolomics, 12, 149. doi:10.1007/s11306-016-1094-6
4.
BenjaminiY.HochbergY. (1995). Controlling the false discovery rate: A practical and powerful approach to multiple testing. Journal of the Royal Statistical Society. Series B (Methodological), 57, 289–300.
5.
BlinderV.EberleC.PatilS.GanyF. M.BradleyC. J. (2017). Women with breast cancer who work for accommodating employers more likely to retain jobs after treatment. Health Affairs, 36, 274–281. doi:10.1377/hlthaff.2016.1196
6.
BowerJ. E.GanzP. A.DesmondK. A.RowlandJ. H.MeyerowitzB. E.BelinT. R. (2000). Fatigue in breast cancer survivors: Occurrence, correlates, and impact on quality of life. Journal of Clinical Oncology, 18, 743–743.
7.
ChiarugiA.DolleC.FeliciR.ZieglerM. (2012). The NAD metabolome—A key determinant of cancer cell biology. Nature Reviews Cancer, 12, 741–752.
8.
ChoH. J.SavitzJ.DantzerR.TeagueT. K.DrevetsW. C.IrwinM. R. (2017). Sleep disturbance and kynurenine metabolism in depression. Journal of Psychomatic Research, 99, 1–7. doi:10.1016/j.jpsychores.2017.05.016
9.
CleelandC.RyanK. (1994). Pain assessment: Global use of the Brief Pain Inventory. Annals of the Academy of Medicine, Singapore, 23, 129–138.
10.
DantzerR. (2017). Role of the kynurenine metabolism pathway in inflammation-induced depression: Preclinical approaches. In DantzerR.CapuronL. (Eds.), Current topics in behavioral neuroscience 31: Inflammation-associated depression: Evidence, mechanisms and implications (pp. 117–138). Cham, Switzerland: Springer International Publishing AG.
11.
DoddM. J.MiaskowskiC.PaulS. M. (2001). Symptom clusters and their effect on the functional status of patients with cancer. Oncology Nursing Forum, 28, 465–470.
12.
DougadosM.SoubrierM.AntunezA.BalintP.BalsaA.BuchM. H.…EmeryP. (2014). Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: Results of an international, cross-sectional study (COMORA). Annals of the Rheumatic Diseases, 73, 62–68.
13.
FordI.NorrieJ. (2016). Pragmatic trials. New England Journal of Medicine, 375, 454–463.
14.
GikaH.TheodoridisG. (2011). Sample preparation prior to the LC–MS-based metabolomics/metabonomics of blood-derived samples. Bioanalysis, 3, 1647–1661. doi:10.4155/bio.11.122
15.
GuestP. C.RahmouneH. (2017). Blood sampling and preparation procedures for proteomic biomarker studies of psychiatric disorders. In GuestP. (Ed.), Proteomic methods in neuropsychiatric research (pp. 141–147). Cham, Switzerland: Springer.
16.
HuS.ShenG.YinS.XuW.HuB. (2009). Melatonin and tryptophan circadian profiles in patients with advanced non-small cell lung cancer. Advances in Therapy, 26, 886–892. doi:10.1007/s12325-009-0068-8
17.
IwataK.WatanabeH.MorisakiT.MatsuzakiT.OhmuraT.HamadaA.SaitoH. (2007). Involvement of indoxyl sulfate in renal and central nervous system toxicities during cisplatin-induced acute renal failure. Pharmaceutical Research, 24, 662–671.
18.
JonesS. M. W.LaCroixA. Z.LiW.ZaslavskyO.Wassertheil-SmollerS.WeitlaufJ.…DanhauerS. C. (2015). Depression and quality of life before and after breast cancer diagnosis in older women from the Women’s Health Initiative. Journal of Cancer Survivorship, 9, 620–629. doi:10.1007/s11764-015-0438-y
19.
KamalK. M.CovveyJ. R.DashputreA.GhoshS.ShahS.BhosleM.ZackerC. (2017). A systematic review of the effect of cancer treatment on work productivity of patients and caregivers. Journal of Managed Care & Specialty Pharmacy, 23, 136–162.
20.
KellyJ. R.KennedyP. J.CryanJ. F.DinanT. G.ClarkeG.HylandN. P. (2015). Breaking down the barriers: The gut microbiome, intestinal permeability and stress-related psychiatric disorders. Frontiers in Cellular Neuroscience, 9, 392. doi:10.3389/fncel.2015.00392
21.
KimS.MillerB. J.StefanekM. E.MillerA. H. (2015). Inflammation-induced activation of the indoleamine 2,3-dioxygenase pathway: Relevance to cancer-related fatigue. Cancer, 121, 2129–2136. doi:10.1002/cncr.29302
22.
LabusJ.MayerE.JarchoJ.KilpatrickL.EversE.BackesW.…van NieuwenhovenM. (2011). Acute tryptophan depletion alters the effective connectivity of emotional arousal circuitry during visceral stimuli in healthy women. Gut, 60, 1196–1203.
23.
LairdB. J.McMillanD. C.FayersP.FearonK.KaasaS.FallonM. T.KlepstadP. (2013). The systemic inflammatory response and its relationship to pain and other symptoms in advanced cancer. The Oncologist, 18, 1050–1055.
24.
LangfordD. J.PaulS. M.CooperB.KoberK. M.MastickJ.MeliskoM.…CartwrightF. (2016). Comparison of subgroups of breast cancer patients on pain and co-occurring symptoms following chemotherapy. Supportive Care in Cancer, 24, 605–614.
25.
LaumetG.ZhouW.DantzerR.EdralinJ. D.HuoX.BudacD. P.…KavelaarsA. (2017). Upregulation of neuronal kynurenine 3-monooxygenase mediates depression-like behavior in a mouse model of neuropathic pain. Brain, Behavior, and Immunity, 66, 94–102. doi:10.1016/j.bbi.2017.07.008
26.
LindbohmM. L.KuosmaE.TaskilaT.HietanenP.CarlsenK.GudbergssonS.GunnarsdottirH. (2014). Early retirement and non-employment after breast cancer. Psycho-Oncology, 23, 634–641.
27.
LiuC. S.AdibfarA.HerrmanN.GallagherD.LactôtK. L. (2017). Evidence for inflammation-associated depression. In DantzerR.CapuronL. (Eds.), Current topics in behavioral neuroscience 31: Inflammation-associated depression: evidence, mechanisms and implications (pp. 3–30). Cham, Switzerland: Springer International Publishing AG.
28.
LyonD.ElmoreL.AboalelaN.Merril-SchoolsJ.McCainN.StarkweatherA.…Jackson-CookC. (2014). Potential epigenetic mechanism(s) associated with the persistence of psychoneurological symptoms in women receiving chemotherapy for breast cancer: A hypothesis. Biological Research for Nursing, 16, 160–174. doi:10.1177/1099800413483545
29.
LyonD.KellyD.WalterJ.BearH.ThackerL.ElswickR. K. (2015). Randomized sham controlled trial of cranial microcurrent stimulation for symptoms of depression, anxiety, pain, fatigue and sleep disturbances in women receiving chemotherapy for early-stage breast cancer. SpringerPlus, 4, 369. doi:10.1186/s40064-015-1151-z
30.
MendozaT. R.WangX. S.CleelandC. S.MorrisseyM.JohnsonB.WendtJ.HuberS. (1999). The rapid assessment of fatigue severity in cancer patients: Use of the Brief Fatigue Inventory. Cancer, 85, 1186–1196.
31.
MiaskowskiC.ConleyY. P.MastickJ.PaulS. M.CooperB. A.LevineJ. D.…KoberK. M. (2017). Cytokine gene polymorphisms associated with symptom clusters in oncology patients undergoing radiation therapy. Journal of Pain and Symptom Management, 54, 305–316. e303.
32.
MyintA.-M.KimY. K.VerkerkR.ScharpéS.SteinbuschH.LeonardB. (2007). Kynurenine pathway in major depression: Evidence of impaired neuroprotection. Journal of Affective Disorders, 98, 143–151. doi:10.1016/j.jad.2006.07.013
33.
NaviauxR. K.NaviauxJ. C.LiK.BrightA. T.AlaynickW. A.WangL.…GordonE. (2016). Metabolic features of chronic fatigue syndrome. Proceedings of the National Academy of Sciences, 113, E5472–E5480.
34.
PluskalT.CastilloS.Villar-BrionesA.OrešičM. (2010). MZmine 2: Modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data. BMC Bioinformatics, 11, 1.
35.
QuinonesM. P.Kaddurah-DaoukR. (2009). Metabolomics tools for identifying biomarkers for neuropsychiatric diseases. Neurobiology of Disease, 35, 165–176.
36.
RusscherM.ChavesI.LechK.KochB. C.NagtegaalJ. E.DorsmanK. F.…GaillardC. A. (2015). An observational study on disturbed peripheral circadian rhythms in hemodialysis patients. Chronobiology International, 32, 848–857. doi:10.3109/07420528.2015.1048868
37.
SavitzJ.DrevetsW. C.WurfelB. E.FordB. N.BellgowanP. S.VictorT. A.…DantzerR. (2015). Reduction of kynurenic acid to quinolinic acid ratio in both the depressed and remitted phases of major depressive disorder. Brain, Behavior, and Immunity, 46, 55–59.
38.
ShellW. E.PavlikS.RothB.SilverM.BreitsteinM. L.MayL.SilverD. (2016). Reduction in pain and inflammation associated with chronic low back pain with the use of the medical food theramine. American Journal of Therapeutics, 23, e1353–e1362. doi:10.1097/mjt.0000000000000068
39.
StarkweatherA.KellyD. L.ThackerL.WrightM. L.Jackson-CookC. K.LyonD. E. (2017). Relationships among psychoneurological symptoms and levels of C-reactive protein over 2 years in women with early-stage breast cancer. Supportive Care in Cancer, 25, 167–176. doi:10.1007/s00520-016-3400-2
40.
StarkweatherA. R.LyonD. E.ElswickR.JrMontpetitA. J.ConleyY.McCainN. L. (2013). A conceptual model of psychoneurological symptom cluster variation in women with breast cancer: Bringing nursing research to personalized medicine. Current Pharmacogenomics and Personalized Medicine, 11, 224.
41.
StoreyJ. D. (2002). A direct approach to false discovery rates. Journal of the Royal Statistical Society: Series B (Statistical Methodology), 64, 479–498. doi:10.1111/1467-9868.00346
42.
SuhreK.MeisingerC.DöringA.AltmaierE.BelcrediP.GiegerC.…IlligT. (2010). Metabolic footprint of diabetes: A multiplatform metabolomics study in an epidemiological setting. PLoS One, 5, e13953. doi:10.1371/journal.pone.0013953
43.
TörökN.MajláthZ.FülöpF.ToldiJ.VécseiL. (2016). Brain aging and disorders of the central nervous system: Kynurenines and drug metabolism. Current Drug Metabolism, 17, 412–429.
44.
UrsiniF.PipicelliG. (2009). Nutritional supplementation for osteoarthritis. Alternative and Complimentary Therapies, 15, 173–177.
45.
van BuurenS. V.Groothuis-OudshoornK. (2011). Mice: Multivariate imputation by chained equations in R. Journal of Statistical Software, 45. doi:10.18637/jss.v045.i03
46.
YehY.-C.HuangM.-F.LiangS.-S.HwangS.-J.TsaiJ.-C.LiuT.-L.…ChenC.-S. (2016). Indoxyl sulfate, not p-cresyl sulfate, is associated with cognitive impairment in early-stage chronic kidney disease. NeuroToxicology, 53, 148–152. doi:10.1016/j.neuro.2016.01.006
47.
YuB.HeissG.AlexanderD.GramsM. E.BoerwinkleE. (2016). Associations between the serum metabolome and all-cause mortality among African Americans in the Atherosclerosis Risk in Communities (ARIC) study. American Journal of Epidemiology, 183, 650–656. doi:10.1093/aje/kwv213
48.
ZigmondA. S.SnaithR. P. (1983). The Hospital Anxiety and Depression scale. Acta Psychiatrica Scandinavica, 67, 361–370.
